Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
NovImmune
company
About
NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $14M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 1998
- Number Of Employee
- 101 - 250
- Operating Status
- Active
NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$114.80M
NovImmune has raised a total of
$114.80M
in funding over 2 rounds. Their latest funding was raised on
May 12, 2009 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2009 | Series Unknown | $54.80M | 3 | — | — | Detail |
| Jun 1, 2006 | Series B | $46M | 1 | — | — | Detail |
| May 1, 2000 | Series A | $14M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
NovImmune is funded by 3 investors.
LODH Immunology Fund
and Ingro Finanz AG
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
|
— | Series Unknown |
Varuma
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
